Ten commissioners voted to nix GLP-1 drug coverage for weight loss, aligning with a benefit change already embraced by commercial insurers and the Massachusetts Interlocal Insurance Association
Key players today include Mounjaro (tirzepatide) a dual-agonist of GLP-1 and GIP receptors and coming soon, Retatrutide a triple-receptor agonist (GLP-1, GIP and glucagon) that has shown even stronger early results
B-Complex shot supports energy, metabolism, and overall wellness with B vitamins
Topical peptides are useful for certain applications (GHK-Cu copper peptide has reasonable evidence for topical activity), but for the major therapeutic peptides growth hormone secretagogues, BPC-157, Epithalon systemic delivery is required to produce the effects seen in the research literature
Human clinical data show hexarelin increases plasma cortisol and ACTH alongside GH